Xiandi Meng

Changchun, 130062, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Corrigendum to "Injectable hydrogel-assisted local lipopolysaccharide delivery improves immune checkpoint blockade therapy" [Acta Biomaterialia 2025, 194, 153-168].

Corrigendum to "Injectable hydrogel-assisted local lipopolysaccharide delivery improves immune checkpoint blockade therapy" [Acta Biomaterialia 2025, 194, 153-168].

Journal: Acta biomaterialia

Published: July 01, 2026

Nanoparticle-enabled CD40 silencing programs immune tolerance via a DC-Treg-Breg axis in autoimmune myocarditis.

Nanoparticle-enabled CD40 silencing programs immune tolerance via a DC-Treg-Breg axis in autoimmune myocarditis.

Journal: Materials today. Bio

Published: April 13, 2026

Chirality of poly(γ-glutamic acid) directs calcium nanoparticle assembly and adjuvant-like immune activation.

Chirality of poly(γ-glutamic acid) directs calcium nanoparticle assembly and adjuvant-like immune activation.

Journal: Acta biomaterialia

Published: December 23, 2025

Nanozymes for Liver Disease Therapy: Advances in Catalytic Activity, Targeting Strategies, and Clinical Translation.

Nanozymes for Liver Disease Therapy: Advances in Catalytic Activity, Targeting Strategies, and Clinical Translation.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 19, 2025

A Biomimetic Nanoparticle System Intercepts and Degrades Thrombospondin-1 to Restore Vascular Homeostasis After Ischemic Injury.

A Biomimetic Nanoparticle System Intercepts and Degrades Thrombospondin-1 to Restore Vascular Homeostasis After Ischemic Injury.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: November 27, 2025

Cationic lipid-modified PEG-PLGA nanoparticles facilitate effective dendritic cell reprogramming to alleviate T cell-mediated autoimmunity in EAE.

Cationic lipid-modified PEG-PLGA nanoparticles facilitate effective dendritic cell reprogramming to alleviate T cell-mediated autoimmunity in EAE.

Journal: Biomaterials

Published: April 29, 2025

Controlled Delivery of C-C Motif Chemokine Ligand 25 by a Hydrogel for Tumor Microenvironment Remodeling in Triple Negative Breast Cancer.

Controlled Delivery of C-C Motif Chemokine Ligand 25 by a Hydrogel for Tumor Microenvironment Remodeling in Triple Negative Breast Cancer.

Journal: Acta biomaterialia

Published: March 16, 2025

Injectable hydrogel-assisted local lipopolysaccharide delivery improves immune checkpoint blockade therapy.

Injectable hydrogel-assisted local lipopolysaccharide delivery improves immune checkpoint blockade therapy.

Journal: Acta biomaterialia

Published: July 17, 2024

Optimized lipid nanoparticles enable effective CRISPR/Cas9-mediated gene editing in dendritic cells for enhanced immunotherapy.

Optimized lipid nanoparticles enable effective CRISPR/Cas9-mediated gene editing in dendritic cells for enhanced immunotherapy.

Journal: Acta pharmaceutica Sinica. B

Published: April 17, 2024

Enhancing ovarian cancer treatment with maleimide-modified Pt(IV) prodrug nanoparticles.

Enhancing ovarian cancer treatment with maleimide-modified Pt(IV) prodrug nanoparticles.

Journal: Materials today. Bio

Published: April 15, 2024

Impacts of cationic lipid-DNA complexes on immune cells and hematopoietic cells in vivo.

Impacts of cationic lipid-DNA complexes on immune cells and hematopoietic cells in vivo.

Journal: Biomaterials science

Published: March 19, 2024

Targeted delivery strategies: The interactions and applications of nanoparticles in liver diseases.

Targeted delivery strategies: The interactions and applications of nanoparticles in liver diseases.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: February 27, 2024

Showing 1-12 of 21

Last Updated: 09/26/2026